Storia della carriera di Daniel-Adriano Silva
Precedenti posizioni note di Daniel-Adriano Silva
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NEUROGENE INC. | Chief Tech/Sci/R&D Officer | 01/12/2003 | 01/03/2021 |
| Founder | 01/12/2003 | 01/03/2021 |
Formazione di Daniel-Adriano Silva
| Universidad Nacional Autónoma de México | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Messico | 2 |
| Stati Uniti | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Daniel-Adriano Silva
- Esperienza
